Presentation:

Pathways to Value: Biopharma’s Options for Global Expansion

On October 20, 2020, Blue Matter led a webinar in coordination with Fierce Markets entitled, Pathways to Value: Biopharma’s Options for Global Expansion.  Speakers were:

  • Theo Manolikas, Principal, Blue Matter Consulting (moderator)
  • Thomas Lackner, Senior Vice President, Head of Europe, Apellis Pharmaceuticals
  • Michelle Lock, Former Senior Vice President, Head of Europe, Sage Therapeutics

During the webinar, the speakers:

  1. Identified the key pathways companies use to enter ex-US markets (e.g., licensing, partnering, “going it alone”)
  2. Discussed the factors that might favor one pathway over another
  3. Outlined a framework that companies can use to decide the optimum pathway for their situations
  4. Provided insights from their experience in ex-US markets

The presentation that was used to facilitate the session is available for download via this page.

Download
  • This field is for validation purposes and should be left unchanged.